Delphia (USA)’s Lam Research LRCX Stock Holding History

Delphia (USA)’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-16,030	Closed	-$850K	–	275
2023 Q1	$850K	Sell	16,030 -510	-3%	-$25K	1.04%	6
2022 Q4	$695K	Buy	+16,540	New	+$692K	0.8%	14

Other funds holding LRCX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Delphia (USA)'s LRCX Position: Q2 2023 in Review

Delphia (USA) sold out of Lam Research (LRCX) in Q2 2023, closing a stake of 16,030 shares — an estimated $850K sold.

Delphia (USA) first reported a position in LRCX in Q4 2022 and held it in 2 quarters. The position peaked at $850K in Q1 2023. 1,433 funds tracked by Wall St. Rank hold LRCX as of Q2 2023.

Delphia (USA) reported no remaining Lam Research position as of Q2 2023 after selling out during the quarter.
Delphia (USA) sold 16,030 Lam Research shares in Q2 2023, an estimated $850K.
Delphia (USA) first reported a position in Lam Research in Q4 2022 and held it in 2 quarters.
Delphia (USA)'s Lam Research position peaked at $850K in Q1 2023.
1,433 funds tracked by Wall St. Rank held Lam Research as of Q2 2023.

Based on Delphia (USA)'s 13F filing for Q2 2023, filed 14 Aug 2023.